Fintel reports that on August 5, 2024, METZLER EQUITIES upgraded their outlook for Carl Zeiss Meditec AG - Depositary Receipt () (OTCPK:CZMWY) from Hold to Buy. As of August 6, 2024, the average ...

In the first three months of the new financial year, the company recorded revenues of EUR 219.0m (previous year: EUR 210.3m) and EBIT of EUR 31.2m (previous year: EUR 28.3m). The EBIT margin improved ...

"ZEISS continues to be at the forefront of optical and digital innovation, advancing our clinical workflows to be more efficient and empowering for doctors and surgeons around the world to deliver ...

Acquisition will extend the company's leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment D.O.R.C., a leading player in the retinal surgical ...

Carl Zeiss Meditec (($GB:0DHC)) announced an update on their ongoing clinical study. Study Overview: Carl Zeiss Meditec AG is conducting a study ...

Hello ladies and gentlemen and welcome to the Carl Zeiss Meditec AG Analyst Conference Call for the Six Months Results 2023/2024. At this time, all participants have been placed on a listen-only mode.

At EURETINA 2025, ZEISS Medical Technology combines its diagnostic, surgical and digital technologies to support healthcare professionals in advancing retinal care: "At ZEISS, we continue to enhance ...

Please provide your email address to receive an email when new articles are posted on . The stolen Zeiss files acquired by Topcon included highly confidential information. Topcon has agreed to pay a ...

NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex ® with noninvasive imaging of ...